Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease. (2021)
Attributed to:
Biominerals in Health and Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ndt/gfaa116
PubMed Identifier: 32651955
Publication URI: http://europepmc.org/abstract/MED/32651955
Type: Journal Article/Review
Volume: 36
Parent Publication: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Issue: 8
ISSN: 0931-0509